News Daily News INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease Michael O'Riordan July 12, 2022
News Daily News LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD Michael O'Riordan July 11, 2022
News Daily News New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT Caitlin E. Cox July 08, 2022
News Features A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts Shelley Wood July 07, 2022
News Daily News Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines Michael O'Riordan July 06, 2022
News Daily News Weekend Warriors vs Regular Exercisers: Some Insights, More Questions Yael L. Maxwell July 06, 2022
News Daily News Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes Todd Neale July 04, 2022
News Daily News USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits Yael L. Maxwell June 23, 2022
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Conference News TVT 2022 Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry Michael O'Riordan June 13, 2022
Presentation TVT 2022 TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials Presenter: Mahesh V. Madhavan June 10, 2022
Presentation TVT 2022 Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials Presenter: Geraldine Ong, Gilbert H. L. Tang, Yan Topilsky June 10, 2022
News Daily News Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis Caitlin E. Cox June 10, 2022
News Conference News TVT 2022 No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest Michael O'Riordan June 09, 2022
News Daily News SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients L.A. McKeown June 09, 2022
Presentation TVT 2022 Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials Presenter: Ashwin Nathan June 08, 2022
Presentation TVT 2022 First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials Presenter: Georg Nickenig June 08, 2022